Fig. 1
From: Polymorphisms of IFN signaling genes and FOXP4 influence the severity of COVID-19
Comparison of neutralizing antibody titers among COVID-19 patients. A The comparison of neutralizing antibody titers between severe or critical COVID-19 patients (designated as cases) and mild or moderate patients (designated as controls). B The comparison of neutralizing antibody titers between FOXP4 rs1886814 AA + AC genotype and CC genotype. C The comparison of neutralizing antibody titers between FOXP4 rs2894439 GG genotype and GA + AA genotype. D The comparison of neutralizing antibody titers between MX1 rs17000900 CC genotype and CA + AA genotype in males